Stem Cell Therapeutic and Research Reauthorization Act of 2026
United States119th CongressS-4109Senate
Updated: Jun 22, 2026
Summary
This bill reauthorizes and extends critical stem cell research and transplantation programs established under the Stem Cell Therapeutic and Research Act of 2005. It specifically ensures the continued operation of the C.W. Bill Young Cell Transplantation Program . The legislation appropriates $33,009,000 annually for the C.W. Bill Young Cell Transplantation Program for fiscal years 2027 through 2031. Additionally, it extends the authorization for the vital cord blood inventory program , pushing its expiration date from 2026 to 2031, thereby supporting ongoing access to cord blood units for patients.
Bill texts
All available records shown.
Timeline
Latest companion bill action
HR-5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)
Senate
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Senate
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Senate
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Senate